Will AbbVie’s $10.9 Billion Acquisition Shape Its Dividend?
AbbVie just agreed to buy Apogee Therapeutics for $10.9 billion in cash. This move could reshape the company’s cash f...
Before investing in 2023, it's vital to learn key concepts. Equip yourself with knowledge to ensure smart investment choices.
17,856 articlesAbbVie just agreed to buy Apogee Therapeutics for $10.9 billion in cash. This move could reshape the company’s cash f...
A wave of options activity suggests a bearish tilt for Tesla ahead of its Q2 earnings, with net short delta near $550...
A high-profile wedding can feel overwhelming, but a simple personal message can change how guests perceive the event—...
In the first half of 2026, Vertiv soared as AI data centers pushed demand for cooling and power solutions. This artic...
The YieldMax NVDA Option Income Strategy ETF has drawn attention for its high advertised yield, but market dynamics a...
Amazon shocks privacy watchers by ending its partnership with Flock Safety after a controversial Super Bowl ad. The m...
Apple shares regained ground as AI plans take center stage ahead of a major March event. This guide breaks down what’...
The Ethereum Foundation lays out a 2026 roadmap centered on post-quantum security and bigger gas limits, reorganizing...
Bitcoin's Divergence From Nasdaq raises questions about dollar liquidity and credit conditions. This article breaks d...
Ford's China negotiations could redefine its growth trajectory. This article explains the real reason investors shoul...
New Mexico is moving to fund universal child care for all families using a windfall from oil and gas revenues, backed...
Forum Energy's latest earnings reveal how the company balances growth with cash flow in volatile markets. This guide ...